U.S. Pharma Stock News

NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Is Zebra Technologies’ (ZBRA) New Orchestrated Care Push Quietly Redefining Its Hospital Workflow Role?

Earlier this month, Zebra Technologies introduced its Orchestrated Care framework and DS82-HC Series healthcare scanner at the HIMSS26 conference in Las Vegas, showcasing solutions that connect patient touchpoints, unify clinician communications, and digitize hospital asset tracking. An important angle for investors is how this healthcare-focused framework leverages Zebra’s existing portfolio across mobile devices, RFID, and real-time location systems to deepen its role inside hospitals’...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

Principal Financial Group Expands Southeast Dental Reach With DentaNet Deal

Principal Financial Group (NasdaqGS:PFG) is acquiring DentaNet, the largest dental provider network in Alabama. The deal expands Principal's dental and specialty benefits presence across the Southeast. The transaction adds a broad network of dental providers serving employers and members in the region. For you as an investor, this move highlights how Principal Financial Group is focusing on fee based benefits businesses such as dental and specialty coverage. Employer sponsored benefits have...
NYSE:KBR
NYSE:KBRProfessional Services

Is KBR (KBR) Now At An Attractive Price After Recent Share Price Weakness

If you are looking at KBR and wondering whether the recent share price leaves it cheap or expensive, you are not alone. This review focuses squarely on what you might be paying for each dollar of the business. KBR shares last closed at US$36.79, with returns of an 8.3% decline over 7 days, a 16.0% decline over 30 days, a 9.2% decline year to date, and a 25.1% decline over 1 year, while the 5 year return sits at 19.6%. Recent news around KBR has focused on its role as an engineering and...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Five9 (FIVN) Valuation Check After Recent Share Price Weakness

Five9: Recent Returns Put Cloud Contact Center Valuation in Focus With no single headline event driving the move, Five9 (FIVN) has drawn attention after recent share price declines, raising fresh questions about how investors are currently valuing its contact center cloud platform. See our latest analysis for Five9. Recent trading has been tough for Five9, with a 1-day share price return of a 3.16% decline, a 7-day share price return of a 10.91% decline and a 90-day share price return of a...
NYSE:RYAN
NYSE:RYANInsurance

Is Ryan Specialty Holdings (RYAN) Now Attractive After A 46.5% One-Year Share Price Slide

If you are wondering whether Ryan Specialty Holdings is attractively priced or just a value trap, this article will walk you through what the current numbers actually say. The share price, which last closed at US$36.17, has seen sharp moves recently, with returns of an 8.1% decline over 7 days, a 19.4% decline over 30 days, a 28.5% decline year to date, and a 46.5% decline over the past year. Recent coverage of Ryan Specialty has focused on its position as a specialty insurance distributor...
NYSE:ICE
NYSE:ICECapital Markets

ICE MERS eRegistry Milestone Deepens Role In Mortgage Digitization

Intercontinental Exchange (NYSE:ICE) reports that its MERS eRegistry has surpassed 3,000,000 eNotes. The milestone reflects expanding use of electronic mortgage promissory notes across a wide range of lenders. This threshold highlights growing adoption of ICE's digital infrastructure in the US mortgage market. For you as an investor, this milestone sits at the core of what NYSE:ICE does in financial plumbing, beyond its better known exchange and data businesses. The MERS eRegistry is a key...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

Assessing JOYY (JOYY) Valuation After Earnings Rebound Dividends And Share Buybacks

JOYY (JOYY) just wrapped up a busy few days, pairing a completed share repurchase program with fresh earnings, forward guidance, and both regular and special dividends that put shareholder returns in focus. See our latest analysis for JOYY. Even with the fresh earnings, dividend news and completed buyback, JOYY’s share price has been softer in the short term, with a 30 day share price return of 5.38% and year to date share price return of 5.44%. By contrast, the 1 year total shareholder...
NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Using Litigation To Reinforce Or Complicate Its Jo Malone Brand Strategy?

Estée Lauder Companies has taken legal action against perfumer Jo Malone, her brand Jo Loves, and Zara’s UK unit, alleging breach of contract, trademark infringement, and passing off over the use of the “Jo Malone” name on jointly marketed fragrances. The dispute spotlights how aggressively Estée Lauder is prepared to defend the Jo Malone London brand equity it acquired in 1999, with potential implications for legal costs, licensing practices, and brand management across its fragrance...
NYSE:NRP
NYSE:NRPOil and Gas

The Bull Case For Natural Resource Partners (NRP) Could Change Following Weaker 2025 Results And Special Payout

Natural Resource Partners L.P. recently reported fourth-quarter and full-year 2025 results showing year-over-year declines in revenue and net income, and its board declared a special cash distribution of US$0.12 per common unit to be paid on March 17, 2026, to unitholders of record on March 10, 2026. The combination of softer earnings and a one-time cash payout highlights how the partnership is balancing current income returns to unitholders with a period of lower operating results. Next,...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

PENN Entertainment Hotel Expansion Tests Value Of Brick And Mortar Investments

PENN Entertainment (NasdaqGS:PENN) plans a major expansion at Hollywood Casino Columbus with a new 203 room hotel tower. The upscale hotel is scheduled to open in June 2026 as part of a broader upgrade to the property. The project includes an expanded high limit table games room and is expected to create new local jobs. PENN Entertainment, which runs casinos, retail sportsbooks and online gaming platforms, is adding more hospitality capacity at one of its key Ohio properties. For investors...
NYSE:OLN
NYSE:OLNChemicals

Assessing Olin’s (OLN) Valuation After Full-Year Results And Recent Share Price Rebound

Why Olin is on investors’ radar today Olin (OLN) is drawing attention after publishing full-year figures that combine revenue of $6,780.8 million, a net income loss of $100.5 million, and annual revenue and net income growth rates of 2.24% and 83.97%, respectively. See our latest analysis for Olin. The full year update comes as Olin’s share price has moved sharply in the short term, with a 9.42% 1 day share price return and a 20.70% year to date share price return, while there has been a...
NYSE:INVH
NYSE:INVHResidential REITs

Invitation Homes Faces FTC Settlement And Housing Bill Cash Flow Test

Invitation Homes agreed to a $47.2 million settlement with the FTC related to allegedly deceptive leasing practices affecting more than 400,000 renters. The settlement includes monetary relief and requirements to change how the company handles fees and security deposits. Separately, Congress is advancing a bill that would limit how long large investors like Invitation Homes can hold newly built single family rental homes before selling them to individual buyers. Invitation Homes...
OTCPK:AITX.D
OTCPK:AITX.DElectronic

A Look At Artificial Intelligence Technology Solutions (OTCPK:AITX) Valuation After New RAD Orders And Planned Stock Split

Stock split and new RAD orders draw fresh attention to AITX Artificial Intelligence Technology Solutions (AITX) is back in focus after announcing a planned 1 for 100 stock split, alongside new orders for its RAD security devices powered by the SARA agentic AI platform. Existing and newly signed channel partners have ordered combinations of ROSA, RIO 360 and SARA licenses, with deployments aimed at retail properties and a new dealer location. For investors, these updates highlight how AITX is...
NYSE:WTS
NYSE:WTSMachinery

Watts Water Recognition Adds ESG Dimension To Share Performance And Valuation

Watts Water Technologies (NYSE:WTS) has been recognized on Newsweek’s 2026 Most Charitable Companies list. The award highlights the company’s philanthropic impact and ongoing community engagement efforts. For investors tracking Watts Water Technologies at a share price of $303.28, this new recognition adds another dimension to a story that has recently centered on financial results and valuation. The stock has returned 8.9% year to date and 48.0% over the past year, while the 3 year and 5...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Advisor Moves Test LPL Financial Story On Growth And Retention

Furstenau Financial, a large wealth advisory team, has left LPL Financial Holdings for Carson Group, taking its client relationships to a rival platform. At the same time, LPL has added Legacy Ridge Private Wealth as a new independent practice through its Strategic Wealth model. These moves highlight both competitive pressures on LPL’s advisor network and the firm’s efforts to attract and support new practices. For investors watching LPL Financial Holdings (NasdaqGS:LPLA), these advisor...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts

Exelixis (EXEL) is back on investor radars after six analysts raised their earnings forecasts for fiscal 2026, citing the company’s oncology pipeline and their growth expectations as key reasons for the revised outlook. See our latest analysis for Exelixis. Even with the recent analyst optimism, Exelixis’ shares have cooled slightly, with a 30 day share price return of a 4.21% decline and a year to date share price return of a 5.53% decline. At the same time, the 1 year total shareholder...
NYSE:LYB
NYSE:LYBChemicals

US Stock Market Today S&P 500 Futures Slip As Yields And Energy Costs Climb

The Morning Bull - US Market Morning Update Friday, Mar, 13 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.2%, as investors react to a fresh jump in government bond yields and renewed energy worries. The US 10 year yield is around 4.26%, which makes borrowing more expensive and can pressure valuations for growth focused companies. At the same time, commodity futures are higher and the US is weighing a temporary shipping rule waiver to ease an...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Assessing Verra Mobility (VRRM) Valuation After Prolonged Share Price Weakness

Why Verra Mobility Is On Investors’ Radar Today Verra Mobility (VRRM) has seen pressure on its share price in recent months, with negative returns over the past month, past 3 months, year to date, and the past year putting recent performance in focus for investors. See our latest analysis for Verra Mobility. With the share price at US$15.16 and a 30 day share price return of an 18.8% decline, Verra Mobility’s momentum has been fading, and its 1 year total shareholder return of a 24.95%...
NYSE:ALG
NYSE:ALGMachinery

Soft Q4 Results And Restructuring Year Might Change The Case For Investing In Alamo Group (ALG)

In March 2026, Alamo Group Inc. reported fourth-quarter 2025 sales of US$373.65 million and net income of US$15.51 million, both down from the prior year, with full-year earnings per share from continuing operations also lower than in 2024. Management described 2025 as a transitional year involving restructuring and sharper priorities, while the company missed analyst expectations and posted the weakest performance versus estimates in its agricultural machinery peer group. Against this...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Is It Time To Reconsider Mattel (MAT) After The Recent Share Price Slide

If you are wondering whether Mattel's current share price reflects its true worth, this article will walk through what the numbers are saying about the stock's value. Mattel recently closed at US$16.22, with returns of 1.2% over 7 days, a 23.0% decline over 30 days, and year to date and 1 year returns of 19.1% and 17.5% declines respectively. These moves may have shifted how the market views both its potential and its risks. Recent coverage around Mattel has focused on its position in the...
NYSE:HL
NYSE:HLMetals and Mining

Is It Too Late To Consider Hecla Mining (HL) After Its 256% One Year Surge

If you are wondering whether Hecla Mining's share price still reflects its underlying value after a strong run, this article walks through what the numbers are actually saying about the stock. The shares last closed at US$20.53, with returns of a 1.3% decline over the past week, a 10.7% decline over the past month, gains of 8.8% year to date, 256.4% over the last year, 286.1% over three years, and 216.6% over five years. Recent headlines around Hecla Mining have focused on the company as a...
NYSE:MSGS
NYSE:MSGSEntertainment

A Look At Madison Square Garden Sports (MSGS) Valuation After Increased Stakes From Gabelli And GAMCO

Recent filings show Mario Gabelli and GAMCO Investors increasing their positions in Madison Square Garden Sports (MSGS), highlighting the New York Knicks and Rangers as core assets that some investors view as potentially undervalued opportunities. See our latest analysis for Madison Square Garden Sports. At a share price of $312.31, Madison Square Garden Sports has given investors a 31.53% 3 month share price return and a 68.13% 1 year total shareholder return, suggesting momentum has been...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Assessing Cognex (CGNX) Valuation After Strong 1 Year Returns And A High P/E Multiple

Why Cognex may be on your radar now Cognex (CGNX) has drawn attention after a mixed stretch in the share price, with a small pullback over the past week following gains over the past month and the past 3 months. See our latest analysis for Cognex. At a share price of US$48.77, Cognex has given investors a 36.8% 90 day share price return and a 62.47% 1 year total shareholder return, which signals building momentum despite the recent 1 day and 7 day pullback. If Cognex's recent move has you...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Trials Progress And Cash Raise Reframe Soquelitinib Risk Reward Profile

Corvus Pharmaceuticals has moved its lead candidate, soquelitinib, into late-stage Phase 3 and Phase 2 trials across several indications. The company raised $189 million in a follow-on offering, which it says extends its cash runway into 2028. Corvus Pharmaceuticals (NasdaqGM:CRVS) is drawing attention after pushing soquelitinib into more advanced clinical trials while securing fresh capital to support the work. The stock trades at $16.01, with very large 3-year and 1-year returns, and a...